位置:成果数据库 > 期刊 > 期刊详情页
白杨素对顺铂及喜树碱诱导肝肿瘤细胞HepG2凋亡的增敏作用
  • ISSN号:1001-2494
  • 期刊名称:《中国药学杂志》
  • 时间:0
  • 分类:R730.1[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]中山大学公共卫生学院,广东广州510080, [2]广东省疾病预防控制中心,广东广州511430
  • 相关基金:国家自然科学基金资助项目(81202199);广东省医学科研基金fA2915055)
中文摘要:

目的:探讨白杨素增强顺铂抗肿瘤作用的最佳条件并筛选敏感细胞。方法:设立阴性对照组、空白调零组及40μmol/L白杨素、5.0μg/mL顺铂、40μmol/L白杨素+5.0μg/mL顺铂3个处理组,选取人结直肠癌细胞(HCT-116)、人鼻咽癌细胞(CNE1)、人肝癌细胞(HepG2)、人胃癌细胞(BGC-823)分别作用24 h。采用四甲基噻唑蓝(MTT)法测定肿瘤细胞的增殖抑制率,采用Hoechst33342荧光染色法测定诱导肿瘤细胞的凋亡率,通过抑制率和凋亡率筛选出敏感细胞。采用L9(3^3)正交设计方法,设立3个白杨素水平(10、20、40μmol/L),3个顺铂水平(13、2.5、5.0μg/mL),以及3种作用时间(12、74、36 h)处理敏感细胞,确定白杨素增强顺铂抗肿瘤作用的最佳作用条件。结果:与白杨素或顺铂单独处理组相比,MTT试验结果表明,白杨素联合顺铂作用组对上述4种肿瘤细胞增殖的抑制率均明显增加,差异均具有统计学意义(P均〈0.01);Hoechst 33342染色实验发现,白杨素联合顺铂作用组诱导各肿瘤细胞的凋亡率亦均明显增加(P均〈0.01)。白杨素联合顺铂作用组对人胃癌细胞BGC-823的增殖抑制率为(78.0±2.0)%、诱导细胞的凋亡率为(72.3±6.5)%。在4种细胞中,人胃癌细胞株BGC-823对白杨素联合顺铂抗肿瘤作用最敏感。正交实验的体外模型结果表明,最佳作用条件为白杨素40μmol/L联合顺铂5.0μg,mL,作用时间24 h。结论:白杨素能增强顺铂抑制人肿瘤细胞增殖和诱导人肿瘤细胞凋亡的作用。人胃癌细胞BGC-823是白杨素和顺铂联合作用的敏感细胞株。

英文摘要:

OBJECTIVE: To study the anti-tumor effect of cisplatin by chrysin (ChR) in vitro. METHODS: Cultured cells from human colorectal cancer (HCT-116),gastric cancer (BGC-823),nasopharyngeal carcinoma (CNE1) and liver cancer (HepG2) were treated by chrysin (40 μmol/L),cisplatin (5.0 μg/mL),and chrysin (40 μmol/L)+cisplatin (5.0 μg/mL) separately for 24 hours. The inhibitory rate of tumor cells was determined by MTT assay. The apoptosis rate of tumor cells was determined by Hoechst 33342 fluorescence staining. The sensitive cell line was identified by the inhibition rate and apoptosis index. The L9(33) orthogonal design of three levels of chrysin (10,20,40 μmol/L),three levels of cisplatin (1.3,2.5,5.0 μg/mL),and three time-points (12,24,36 h) was used to screen for the best combination effect of chrysin and cisplatin in the sensitive cells. RESULTS: Among all cell lines,the MTT assay showed that the inhibition rates from exposure to the combination of chrysin and cisplatin were significantly higher than that of the single treatment groups of chrysin and cisplatin (P 〈 0.01). Similarly,Hoechst 33342 staining showed that the apoptosis rates from the combined treatment were significantly higher than those from the single treatment groups (P 〈 0.01). From the combined treatment,the inhibitory rate in BGC-823 was (78.0±2.0)% and the apoptosis index was (72.3±6.5)%,indicating that this was the most sensitive among all tested cell lines. The results of in vitro orthogonal experiment showed that the most effective conditions were:40 μmol/L chrysin,5.0 μg/mL cisplatin,and 24 hours of treatment time. CONCLUSION: Chrysin enhanced the inhibitory effect of cisplatin via inhibition of cell proliferation and promotion of apoptosis in human tumor cell lines. Among the tested cell lines,the human gastric cancer cell line BGC-823 was the sensitive one to the combined effect of chrysin and cisplatin.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国药学杂志》
  • 中国科技核心期刊
  • 主管单位:中国科学技术协会
  • 主办单位:中国药学会
  • 主编:桑国卫
  • 地址:北京市朝阳区建外大街四号建外SOHO九号楼18层
  • 邮编:100022
  • 邮箱:zgyxzz@cpa.org.cn
  • 电话:010-58698009
  • 国际标准刊号:ISSN:1001-2494
  • 国内统一刊号:ISSN:11-2162/R
  • 邮发代号:2-232
  • 获奖情况:
  • 首届国家期刊奖,第一、二届全国优秀科技期刊一等奖,中国期刊方阵“双高”期刊
  • 国内外数据库收录:
  • 美国国际药学文摘,美国化学文摘(网络版),荷兰文摘与引文数据库,荷兰医学文摘,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),英国英国皇家化学学会文摘,中国北大核心期刊(2000版)
  • 被引量:54982